Tag: pharmaceuticals

Blog Posts (30)

May 14, 2012

AJOB: An Independent Journal

It has been implied by Carl Elliott and William Heisel that it has ever been claimed that “financial links between the Center for Practical Bioethics, AJOB and Purdue Pharma” exist and that “what reporters may find is that the center is tied up” with AJOB.  …

October 4, 2011

A Duty to Report Dead Ends?

When an investigational agent is being studied by pharma, is there an ethical responsibility to disclose the findings of that research, even if the agent is no longer being studied or being brought to market?…

August 11, 2011

Drug Shortages Hurt Man....and His Best Friend

When a reproductive oncologist in our clinical ethics certificate program did a presentation on drug shortages in oncology last month, I thought perhaps this was just a highly specialized problem.…

September 13, 2010

Guinea-Pigging: It's Not A Real Word, But It's A Real-World Phenomenon

Watch to see the story of “The Life of a Professional Guinea Pig” courtesy of TIME.

Spencer, or as I would describe him a walking human pin cushion (shown below), tells his story of being a healthy volunteer for Phase I research.…

January 25, 2010

"Extraordinary Messiness"

Hollywood has taken up orphan diseases before–remember “Lorenzo’s Oil”? And bioethics movies generally have been increasingly common, even just in the last year.…

November 2, 2009

Q & A on What is a Blockbuster Anti-Wrinkle Cream Worth, Morally Speaking Or How Many Fetuses Does It Take To Make a Great Cosmeceutical

Question: What is it worth to produce a blockbuster anti-wrinkle cream?
Hypothetical Answer from Cosmeceutical Company: A single skin biopsy of a 14-week old voluntarily aborted fetus from a minor with consent from her parents.…

July 21, 2009

Keeping Your Skin Youthful, The Stem Cell Way

Stem cells are, apparently, all the rage in the world of cosmetics. Slather them on your face to keep your face young and ageless or to simply make yourself more beautiful on your eyes, cheeks, or lips.…

May 18, 2009

Lose Your Job, Keep Your Drugs

According to Judith Graham at the Chicago Tribune’s Triage blog, Pfizer has created a new program to allow the unemployed–and thus uninsured–to keep access to their prescription drugs for one year.…

May 1, 2009

Merck Makes Phony Peer-Review Journal

It’s a safe guess that somewhere at Merck today someone is going through the meeting minutes of the day that the hair-brained scheme for the Australasian Journal of Bone and Joint Medicine was launched, and that everyone who was in the room is now going to be fired.…

January 14, 2009

Direct-to-Consumer Ads Fail to Direct Many Consumers

According to MSNBC, direct-to-consumer advertising for pharmaceuticals are cluttering the airwaves with offers to cure Americans of their bipolar disorder, irritable bowel disease, sleeplessness, acid reflux, high cholesterol and more.…

View More Blog Entries

Published Articles (2)

American Journal of Bioethics: Volume 14 Issue 3 - Mar 2014

The Ethics of Advertising for Health Care Services Yael Schenker, Robert M. Arnold & Alex John London

American Journal of Bioethics: Volume 11 Issue 6 - Jun 2011

It's Time for Bioethics to See Chronic Pain as an Ethical Issue

News (23)

August 19, 2016 8:00 am

Scientists Engineer An Opioid That May Reduce Pain With Less Risk (NPR)

Once people realized that opioid drugs could cause addiction and deadly overdoses, they tried to use newer forms of opioids to treat the addiction to its parent. Morphine, about 10 times the strength of opium, was used to curb opium cravings in the early 19th century. Codeine, too, was touted as a nonaddictive drug for pain relief, as was heroin.


July 28, 2014 4:30 pm

Drugs to increase 'good' cholesterol may not cut deaths

Drugs that have been investigated to increase so-called “good” cholesterol may not prevent deaths, heart attacks or strokes as many hoped, according to a new analysis.

March 25, 2014 2:53 pm

Marijuana pills and sprays ease MS symptoms

There is no cure for the condition, and therapies have proven difficult, as many have serious side effects. But now, relief may come in the form of a medical marijuana pill.

March 13, 2014 3:41 pm

Company Makes Drug Available To Ailing Boy Following Public Outcry

Chimerix, a small and unprofitable biotechnology company, will make an experimental drug available to a young Virginia boy who is suffering from an infection he contracted while being treated for cancer.

July 24, 2012 9:15 am

Ban on pharma meals for physicians overturned (American Medical News)

In May, the Massachusetts Medical Society adopted policy supporting a change in the state’s gift ban so long as the modification conformed to guidelines from the ACCME and the American Medical Association. The AMA Code of Medical Ethics says it is OK for physicians to accept gifts worth $100 or less from industry so long as they benefit patients.

July 18, 2012 10:14 am

M.D. Anderson drug trial raises ethical concerns (Houston Chronicle)

M.D. Anderson’s oversight of clinical trials of the drug AV-203 would violate ethics rules the institution created a decade ago after it failed to tell patients about the financial stake of its then-president, Dr. John Mendelsohn, in his drug Erbitux.  “To me, this is a conflict of interest,” Dr. Leonard Zwelling, an M.D. Anderson professor who helped rewrite the ethics rules, said of the Aveo trial. “There is a system that got bypassed here.”

July 17, 2012 4:01 pm

The Ethics of Sports 'We Need an Open Market for Doping' (Spiegel Online)

It is commonly accepting that doping in sports should be strictly prohibited. But Oxford bio-ethicist Julian Savulescu disagrees. In an interview with SPIEGEL ONLINE on the eve of the London Olympics, he explains why bans are unrealistic and demands an open market for doping.

July 10, 2012 4:28 pm

FDA unveils safety measures for opioid painkillers (Fox News)

Drugmakers that market powerful painkiller medications will be required to fund training programs to help U.S. doctors and other health professionals safely prescribe the drugs, which are blamed for thousands of fatal overdoses each year.  The safety plan released by the Food and Drug Administration on Monday is designed to reduce misuse and abuse of long-acting opioid pain relievers, which include forms of morphine, methadone and oxycodone. The agency’s plan mainly involves educating doctors and patients about appropriate use of the drugs.

July 2, 2012 3:52 pm

Fighting prescription drug abuse, while treating pain, is a health care crisis (Oregon Live)

The abuse, misuse and diversion of prescription drugs is a public health crisis. This is particularly apparent to those of us working in the emergency department, which is the largest ambulatory source of opioid medications. We all too frequently see individuals with untreated addiction issues, with life-threatening overdoses, and trying to obtain opioid medications for recreational use or to sell for profit.

June 6, 2012 12:04 pm

Cancer Doctors Say Some, Not All, Drug Shortages Have Eased (Wall Street Journal)

Doctors who treat cancer say a shortage of oncology drugs has eased, though shortages persist of some chemotherapy drugs that form the backbone of treatment for breast, colon, lung and some other cancers. Hospitals have been struggling with shortages of mostly older, generic drugs for cancer and other ailments for about two years.

View More News Items